Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.6930
-0.0484 (-6.53%)
At close: Apr 21, 2026, 4:00 PM EDT
0.7084
+0.0154 (2.22%)
After-hours: Apr 21, 2026, 7:59 PM EDT
Tenaya Therapeutics Employees
Tenaya Therapeutics had 70 employees as of December 31, 2025. The number of employees decreased by 27 or -27.84% compared to the previous year.
Employees
70
Change (1Y)
-27
Growth (1Y)
-27.84%
Revenue / Employee
n/a
Profits / Employee
-$1,294,243
Market Cap
150.38M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 70 | -27 | -27.84% |
| Dec 31, 2024 | 97 | -43 | -30.71% |
| Dec 31, 2023 | 140 | -1 | -0.71% |
| Dec 31, 2022 | 141 | 35 | 33.02% |
| Sep 30, 2022 | 140 | 40 | 40.00% |
| Jun 30, 2022 | 135 | 50 | 58.82% |
| Mar 31, 2022 | 125 | 50 | 66.67% |
| Dec 31, 2021 | 106 | 31 | 41.33% |
| Sep 30, 2021 | 100 | 25 | 33.33% |
| Jun 30, 2021 | 85 | - | - |
| Mar 31, 2021 | 75 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Humacyte | 184 |
| Fate Therapeutics | 161 |
| Molecular Partners AG | 134 |
| Connect Biopharma Holdings | 64 |
| Biomea Fusion | 41 |
| Spero Therapeutics | 25 |
| Unicycive Therapeutics | 22 |
TNYA News
- 5 weeks ago - Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301's Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy - GlobeNewsWire
- 6 weeks ago - Tenaya Therapeutics Stock Jumps After New Alnylam Deal - Benzinga
- 6 weeks ago - Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments - Reuters
- 6 weeks ago - Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics - GlobeNewsWire
- 7 weeks ago - Tenaya Therapeutics to Participate in the Leerink Partners Global Healthcare Conference 2026 - GlobeNewsWire
- 3 months ago - Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones - GlobeNewsWire
- 4 months ago - Tenaya Stock Plunges After $60 Million Equity Offering - Benzinga